• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

BVI purchases ophthalmic assets from Odyssey

Article

Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions.

 

Waltham, MA-Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions. BVI is a portfolio company of RoundTable Healthcare Partners, an operating-oriented private equity firm focused on the healthcare industry.

“We are excited to bring Odyssey to our customers as a part of the Beaver-Visitec family,” said Tom Kapfer, chief executive officer of BVI. “We are committed to providing high-quality single-use products with the performance and precision clinicians expect. Odyssey is a perfect fit with our goal.”

"BVI and Odyssey both believe in offering the best products to our customers,” added Barbara Tatge, a former owner of Odyssey who will be joining BVI. “This shared value is what attracted us to BVI.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.